PolyGene is a privately held research institute, located in the area of Zurich, Switzerland. Founded in 2002, PolyGene is run by a team of scientists with academic and industrial backgrounds, having notable track records as well in mouse transgenesis as in business management.

PolyGene has a fully functional production site for the establishment of transgenic and knockout mouse lines. The entire site is owned and used exclusively by PolyGene, and is maintained and further developed continuously with highest standards. It is one of the most preferred, leading professional transgenic services in the world, with over 200 completed customer projects with more than 500 individual mouse lines generated for a world-wide clientele.

Transgenic services and co-development opportunities are offered to research laboratories, as well in academia as in the pharmaceutical and biotech industries.

At PolyGene:

 quality and reliability imply relentless quality control and resolute adoption of
   most advanced technologies.
 flexibility entails developing a convincing portfolio of various innovative
   transgene expression systems.
 cost-efficiency is regarded as a crucial topic calling for systematic optimization of
   manufacturing processes.

PolyGene maintains excellent relationships with key researchers in the field of transgenesis, sharing invaluable views in terms of troubleshooting and technological advances.

PolyGene has a strong IP portfolio, includind patent rights on innovative antibiotic -inducible expression systems, used exclusively for transgenic service projects.